Jump to navigation Jump to search
This agent is not commercially available in the United States and is included for historic purposes only.
Diseases for which it was used
History of changes in FDA indication
- 6/18/1990: indicated as adjuvant treatment in combination with 5-fluorouracil after surgical resection in patients with Dukes' stage C colon cancer. (Based on Laurie et al. 1989 & Moertel et al. 1990)
Also known as
- Brand name: Ergamisol